Pernicious Anemia and Vitamin B12 Deficiency Presenting As Pseudothrombotic Microangiopathy and Developing Secondary Thrombocytopenia After Treatment: A Case Report.

pernicious anemia pseudo ttp secondary/reactive thrombocytosis thrombotic thrombocytopenic purpura (ttp)-like syndrome vitamin b12 deficiency anemia

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Dec 2022
Historique:
accepted: 30 11 2022
entrez: 5 1 2023
pubmed: 6 1 2023
medline: 6 1 2023
Statut: epublish

Résumé

Pernicious anemia (PA) is an autoimmune disease secondary to chronic atrophic gastritis leading to vitamin B12 deficiency. Rarely, some patients may develop advanced hematological complications that mimic those of thrombotic thrombocytopenic purpura (TTP). Differentiating these conditions is crucial because they require different management. We present a case of a 68-year-old male who presented with generalized weakness, fatigue, and shortness of breath. This patient had anemia, thrombocytopenia, and a markedly deficient serum level of vitamin B12. The symptoms initially mimicked those associated with TTP, but the activity of ADAMTS 13 was normal. A diagnosis of pseudo-TTP has been made due to vitamin B12 deficiency resulting from PA with reactive thrombocytosis. Ultimately, vitamin B12 deficiency pseudo-TTP should be considered a differential diagnosis for therapy refractory TTP because of its different management strategies ranging from parenteral Vitamin B12 in PA patients with highly favorable outcomes to more advanced treatment with less favorable outcomes in TTP patients.

Identifiants

pubmed: 36601163
doi: 10.7759/cureus.32095
pmc: PMC9804028
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e32095

Informations de copyright

Copyright © 2022, Abosheaishaa et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Clin Lab Haematol. 2006 Feb;28(1):50-6
pubmed: 16430460
SAGE Open Med Case Rep. 2017 Jun 06;5:2050313X17713149
pubmed: 28620491
Am J Med. 2003 Apr 1;114(5):423-5
pubmed: 12714141
J Gen Intern Med. 2021 Jun;36(6):1775-1777
pubmed: 33620630
BMC Hematol. 2015 Dec 01;15:16
pubmed: 26634125
Blood. 1990 Sep 1;76(5):871-81
pubmed: 2393714
Turk J Haematol. 2012 Sep;29(3):248-53
pubmed: 24744668
Case Rep Med. 2017;2017:9410727
pubmed: 28265287
Int J Crit Illn Inj Sci. 2016 Apr-Jun;6(2):89-92
pubmed: 27308258
Autoimmun Rev. 2014 Apr-May;13(4-5):565-8
pubmed: 24424200
Postgrad Med J. 1969 Dec;45(530):754-6
pubmed: 5392350
N Am J Med Sci. 2011 Oct;3(10):472-4
pubmed: 22363087
Clin Pharmacol. 2019 Aug 27;11:127-131
pubmed: 31695518
Intensive Care Med. 2022 Oct;48(10):1382-1396
pubmed: 35960275

Auteurs

Hazem Abosheaishaa (H)

Internal Medicine, Icahn School of Medicine at Mount Sinai, Queens Hospital Center, New York City, USA.
Internal Medicine/Gastroenterology, Cairo University, Cairo, EGY.

Mahmoud Nassar (M)

Internal Medicine, Icahn School of Medicine at Mount Sinai/NYC Health + Hospitals/Queens, New York City, USA.

Muhammad Ghallab (M)

Internal Medicine, Icahn School of Medicine at Mount Sinai, NYC Health and Hospitals/Queens, New York City, USA.

Mohammed Abdelwahed (M)

Pathology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Uniondale, USA.

Amr Ali (A)

Pathology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Uniondale, USA.

Bassel Ibrahim (B)

Internal Medicine, University of Houston, Houston, USA.

Eben Kimball (E)

Internal Medicine, Queens Hospital Center, Jamaica, USA.

Classifications MeSH